NCT00935870

Bioactive Glass as Bone Graft Substitute in Operative Treatment of Bone - a 10 Years Follow-up Study

Bioactive Glass (S53P4) as Bone Graft Substitute in Operative Treatment of Depressed Lateral Condyle Fractures, Benign Bone Tumour Cavities and in Spinal Fusion - a 10 Years Follow-up and Bone Density Study.

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 63 (actual)
• Sponsor: Vivoxid Ltd · Industry
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

The main aim is to evaluate the long-term safety and bone healing in the operated area and to compare bioactive glass granules with autogenous bone as a filler material.

Conditions

• Depressed Lateral Condyle Fracture
• Benign Bone Tumour Cavity
• Spinal Fusion

Interventions

Type	Name	Description
DEVICE	Bioactive glass and/or autogenous bone	No intervention in the current study (10-year follow-up study)

Timeline

• Start date: 2008-01-01
• Primary completion: 2008-06-01
• Completion: 2009-02-01
• First posted: 2009-07-09
• Last updated: 2009-07-09

Locations

1 site across 1 country: Finland